AlgiPharma AS

Quick facts

Phase 2 pipeline

• Alginate oligosaccharide · Gastrointestinal
  Alginate oligosaccharide works by forming a protective barrier on the surface of the mucosa to treat conditions such as gastroesophageal reflux disease (GERD).

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• AlgiPharma AS portfolio CI brief
• AlgiPharma AS pipeline updates RSS